Grifols (GRFS) Current Taxes (2009 - 2025)
Grifols' (GRFS) quarterly Current Taxes came in at $29.1 million in Q4 2025, down 55.36% YoY from $65.2 million in Q4 2024, and down 55.36% on a QoQ basis from $65.2 million in Q4 2024.
Grifols (GRFS) Current Taxes (2009 - 2025) Analysis & Trends
Grifols (GRFS) has 17 years of Current Taxes data on file, last reported at $29.1 million in Q4 2025.
- Quarterly Current Taxes fell 55.36% year-over-year to $29.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.1 million (down 55.36% YoY) and the FY2025 annual result came in at $29.1 million, down 55.36% from the prior year.
- Current Taxes eased to $29.1 million in Q4 2025, from $65.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $65.2 million in Q4 2024 to a low of $5.2 million in Q4 2021.
- A 5-year average of $26.2 million and a median of $16.0 million in 2022 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes soared 317.16% — and 2025, when it plunged 55.36%.
- Tracing GRFS's Current Taxes over 5 years: stood at $5.2 million in 2021, then surged by 209.8% to $16.0 million in 2022, then decreased by 2.37% to $15.6 million in 2023, then soared by 317.16% to $65.2 million in 2024, then sank by 55.36% to $29.1 million in 2025.
- The last three Current Taxes figures came in at $29.1 million (Q4 2025), $65.2 million (Q4 2024), and $15.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.23 Bn | 630.47 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 469.32 Bn | 462.76 Bn | 12.70 Bn | - |
| 3 | Merck | 378.85 Bn | 371.71 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 302.78 Bn | 295.09 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 257.59 Bn | 252.69 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 236.50 Bn | 222.51 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.49 Bn | 179.31 Bn | 6.22 Bn | - |
| 8 | Pfizer | 161.62 Bn | 149.92 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 105.56 Bn | 101.39 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Grifols | 5.51 Bn | 4.50 Bn | - | 29.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.10 Mn |
| Dec 31, 2024 | 65.18 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Dec 31, 2019 | 6.60 Mn |
| Dec 31, 2018 | 2.19 Mn |
| Jun 30, 2018 | 24.20 Mn |
| Dec 31, 2017 | 7.90 Mn |
| Jun 30, 2017 | 23.02 Mn |
| Dec 31, 2016 | 8.59 Mn |
| Sep 30, 2016 | 24.51 Mn |
| Jun 30, 2016 | 36.95 Mn |
| Dec 31, 2015 | 17.75 Mn |
| Sep 30, 2015 | 43.88 Mn |
| Jun 30, 2015 | 107,468.36 |
| Mar 31, 2015 | 113.58 Mn |
| Dec 31, 2014 | 109.31 Mn |
| Sep 30, 2014 | 78.87 Mn |